Stage IV Lymphoepithelioma of the Nasopharynx Completed Phase 1 Trials for Everolimus (DB01590)

IndicationStatusPhase
DBCOND0029528 (Stage IV Lymphoepithelioma of the Nasopharynx)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01637194Cetuximab and Everolimus in Treating Patients With Metastatic or Recurrent Colon Cancer or Head and Neck CancerTreatment